Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001810460 | SCV002059992 | uncertain significance | Monogenic diabetes | 2021-12-31 | reviewed by expert panel | curation | The c.1504C>G variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of leucine to valine at codon 502 (p.(Leu502Val)) of NM_000545.8. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The variant has a REVEL score of 0.557, which is between the ClinGen MDEP thresholds predicting neither a damaging nor benign impact on HNF1A function. Additionally, the c.1504C>G variant was identified in an individual with diabetes; however, the MODY probability is unable to be calculated due to the lack of treatment information (internal lab contributors). Lastly, this variant was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID:23771925, internal lab contributors). In summary, c.1504C>G meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 6/4/2021): PM2_Supporting. |
Gene |
RCV000523345 | SCV000617536 | uncertain significance | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23771925) |
Clinical Genomics, |
RCV002319521 | SCV002604946 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs924150546 with MODY3. | |
Fulgent Genetics, |
RCV005010476 | SCV005634506 | uncertain significance | Diabetes mellitus type 1; Type 1 diabetes mellitus 20; Maturity-onset diabetes of the young type 3; Type 2 diabetes mellitus; Hepatic adenomas, familial; Nonpapillary renal cell carcinoma | 2024-06-10 | criteria provided, single submitter | clinical testing |